Gerlinde Wernig

9.3k citations

34 papers · 3.9k indexed · 2 hit papers · h-index 21

Impact in

Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research

Papers in

Hematology 17
- Chronic Myeloid Leukemia Treatments 10
- Acute Myeloid Leukemia Research 6
Genetics 16
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15

Co-authors: Ross L. Levine D. Gary Gilliland Thomas Mercher Benjamin H. Lee Rachel Okabe Yana Pikman Benjamin L. Ebert Elizabeth McDowell
Journals: Blood (8 papers)Proceedings of the National Academy of Sciences (5 papers)Nature Communications (2 papers)Leukemia (2 papers)Cancer Cell (2 papers)
Partner nations: United States Germany France

In The Last Decade

Gerlinde Wernig

33 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring 2021 · 404 citations

Peers

Countries citing papers authored by Gerlinde Wernig

Since Specialization

Citations

This map shows the geographic impact of Gerlinde Wernig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerlinde Wernig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerlinde Wernig more than expected).

Fields of papers citing papers by Gerlinde Wernig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerlinde Wernig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerlinde Wernig. The network helps show where Gerlinde Wernig may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerlinde Wernig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerlinde Wernig Line = papers co-authored together Gerlinde Wernig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Innate immune cell activation causes lung fibrosis in a humanized model of long COVID Proceedings of the National Academy of Sciences ·Lu Cui, Zhuoqing Fang, Cristabelle Madona De Souza, Tristan Lerbs, Yuan Guan, Irene Li, Vivek Charu, Shih‐Yu Chen, Irving L. Weissman, Gerlinde Wernig	2023	29
2	Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring Science ·Shamik Mascharak, Heather E. desJardins-Park, Michael F. Davitt, Michelle Griffin, Mimi R. Borrelli, Alessandra L. Moore, Kellen Chen, Bryan Duoto, Malini Chinta, Deshka S. Foster, Abra H. Shen, Michael Januszyk, Sun Hyung Kwon, Gerlinde Wernig, Derrick C. Wan, H. Peter Lorenz, Geoffrey C. Gurtner, Michael T. Longaker Hit paper breakdown →	2021	404
3	Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors Proceedings of the National Academy of Sciences ·Lu Cui, Ignacio Moraga, Tristan Lerbs, Camille Van Neste, Stephan Wilmes, Naotaka Tsutsumi, Aaron C. Trotman-Grant, Milica Gakovic, Sarah Andrews, Jason Gotlib, Spyros Darmanis, Martin Enge, Stephen R. Quake, Ian S. Hitchcock, Jacob Piehler, K. Christopher García, Gerlinde Wernig	2020	20
4	CD47 prevents the elimination of diseased fibroblasts in scleroderma JCI Insight ·Tristan Lerbs, Lu Cui, Megan E. King, Tim Chai, Claire Muscat, Leland W.K. Chung, Ryanne A. Brown, Kerri E. Rieger, Tyler Shibata, Gerlinde Wernig	2020	25
5	Expansion of Bone Precursors through Jun as a Novel Treatment for Osteoporosis-Associated Fractures Stem Cell Reports ·Tristan Lerbs, Lu Cui, Claire Muscat, Atif Saleem, Camille Van Neste, Pablo Domizi, Charles K. F. Chan, Gerlinde Wernig	2020	17
6	Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation Nature Communications ·Agnieszka Czechowicz, Rahul Palchaudhuri, Amelia Scheck, Yu Hu, Jonathan Hoggatt, Borja Sáez, Wendy W. Pang, Michael K. Mansour, Tiffany Tate, Yan Yi Chan, Emily Walck, Gerlinde Wernig, Judith A. Shizuru, Florian Winau, David T. Scadden, Derrick J. Rossi	2019	132
7	Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets Biology of Blood and Marrow Transplantation ·Antonia Müller, Dullei Min, Gerlinde Wernig, Robert B. Levy, Víctor Pérez, Samantha Herretes, Mareike Florek, Casey Burnett, Kenneth I. Weinberg, Judith A. Shizuru	2019	14
8	Surgical adhesions in mice are derived from mesothelial cells and can be targeted by antibodies against mesothelial markers Science Translational Medicine ·Jonathan M. Tsai, Rahul Sinha, Jun Seita, Nathaniel B. Fernhoff, Simon Christ, Tim Koopmans, Geoffrey W. Krampitz, Kelly M. McKenna, Liujing Xing, Michael A. Sandholzer, Jennifer Sales, Maia Shoham, Melissa McCracken, Lydia‐Marie Joubert, Sydney Gordon, Nicolas Poux, Gerlinde Wernig, Jeffrey A. Norton, Irving L. Weissman, Yuval Rinkevich	2018	91
9	Direct targeting of the mouse optic nerve for therapeutic delivery Journal of Neuroscience Methods ·Louise A. Mesentier‐Louro, Robert Dodd, Pablo Domizi, Hiroko Nobuta, Marius Wernig, Gerlinde Wernig, Yaping Joyce Liao	2018	8
10	Unifying mechanism for different fibrotic diseases Proceedings of the National Academy of Sciences ·Gerlinde Wernig, Shih‐Yu Chen, Lu Cui, Camille Van Neste, Jonathan M. Tsai, Neeraja Kambham, Hannes Vogel, Yasodha Natkunam, D. Gary Gilliland, Garry P. Nolan, Irving L. Weissman	2017	145
11	Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands Cell ·Ignacio Moraga, Gerlinde Wernig, Stephan Wilmes, Vitalina Gryshkova, Christian Richter, Wan‐Jen Hong, Rahul Sinha, Feng Guo, Hyna Fabionar, Tom S. Wehrman, Peter O. Krutzik, Samuel Demharter, Isabelle Plo, Irving L. Weissman, Péter Mináry, Ravindra Majeti, Stefan N. Constantinescu, Jacob Piehler, K. Christopher García	2015	123
12	STAT5 Is Crucial to Maintain Leukemic Stem Cells in Acute Myelogenous Leukemias Induced by MOZ-TIF2 Cancer Research ·Winnie F. Tam, Patricia S. Hähnel, Andrea Schüler, Benjamin H. Lee, Rachel Okabe, Nan Zhu, Saskia V. Pante, Glen Raffel, Thomas Mercher, Gerlinde Wernig, Ernesto Bockamp, Daniel Sasca, Andreas Kreft, Gertraud W. Robinson, Lothar Hennighausen, D. Gary Gilliland, Thomas Kindler	2012	26
13	Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells Leukemia ·Donghee Kim, Jian Wang, Stephen B. Willingham, R.K. Martin, Gerlinde Wernig, Irving L. Weissman	2012	180
14	EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515L Leukemia ·Gerlinde Wernig, Michael G. Kharas, Ann Mullally, Dena S. Leeman, Rachel Okabe, Tracy I. George, D O Clary, D. Gary Gilliland	2011	14
15	Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells Cancer Cell ·Ann Mullally, Steven Lane, Brian Ball, Christine Megerdichian, Rachel Okabe, Fátima Al‐Shahrour, Mahnaz Paktinat, J. Erika Haydu, Elizabeth Housman, Allegra M. Lord, Gerlinde Wernig, Michael G. Kharas, Thomas Mercher, Jeffery L. Kutok, D. Gary Gilliland, Benjamin L. Ebert	2010	285
16	Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera Cancer Cell ·Gerlinde Wernig, Michael G. Kharas, Rachel Okabe, Sandra Moore, Dena S. Leeman, Dana E. Cullen, Maricel Gozo, Elizabeth McDowell, Ross L. Levine, John Doukas, Chi Ching Mak, Glenn Noronha, Michael Martin, Yon Ko, Benjamin H. Lee, Richard Söll, Ayalew Tefferi, John Hood, D. Gary Gilliland	2008	305
17	MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia PLoS Medicine ·Yana Pikman, Benjamin H. Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L. Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky, Daniel J. DeAngelo, Jennifer Clark, Stephanie J. Lee, Todd R. Golub, Martha Wadleigh, D. Gary Gilliland, Ross L. Levine Hit paper breakdown →	2006	1024
18	JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model Blood ·Thomas Mercher, Gerlinde Wernig, S. A. Moore, Ross L. Levine, Ting-Lei Gu, Stefan Fröhling, David J. Cullen, Roberto D. Polakiewicz, Olivier Bernard, Titus J. Boggon, Ben H. Lee, D. Gary Gilliland	2006	87
19	Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders Hematology ·Ross L. Levine, Gerlinde Wernig	2006	48
20	The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment Proceedings of the National Academy of Sciences ·Gerlinde Wernig, Viktor Janzen, Ralf B. Schäfer, Margit Zweyer, Ulrich Knauf, Oliver Hoegemeier, Rustam R. Mundegar, Stefan Garbe, Sebastian Stier, Thomas Franz, Marius Wernig, A. Wernig	2005	29

About Gerlinde Wernig

Gerlinde Wernig is a scholar working on Hematology, Genetics, Rehabilitation, Rheumatology and Dermatology, having authored 34 papers that have together received 3.9k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Chronic Myeloid Leukemia Treatments (10 papers), Cytokine Signaling Pathways and Interactions (7 papers), Acute Myeloid Leukemia Research (6 papers), Eosinophilic Disorders and Syndromes (6 papers), Wound Healing and Treatments (5 papers), Phagocytosis and Immune Regulation (4 papers) and Kruppel-like factors research (4 papers). The work is most often cited by research in Genetics (2.4k citations), Hematology (1.8k citations), Rheumatology (825 citations), Rehabilitation (252 citations) and Molecular Biology (1.9k citations). Gerlinde Wernig has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Ross L. Levine, D. Gary Gilliland, Thomas Mercher, Benjamin H. Lee, Rachel Okabe, Yana Pikman, Benjamin L. Ebert, Elizabeth McDowell, Maricel Gozo and Sandra Moore. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Nature Communications, Leukemia and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact